Haemato AG
Research Haemato AG (HAEK) on Bullrun: market cap EUR 69.71M, P/E 5.8, dividend yield 0.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHAEK
- ExchangeHM
- CountryGermany
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 69.71M
- P/E5.8
- Dividend yield0.3%
- Financial periodFY2022
- RevenueEUR 248.14M
- Revenue growth-12.9%
- Net incomeEUR 8.19M
- Free cash flowEUR 18.64M
- Gross margin8.7%
Valuation Snapshot
latest market cap is EUR 69.71M; P/E is 5.8; dividend yield is 0.3%.
Peer valuation comparison
Latest P/E is 5.82x versus a Healthcare sector median of 24.46x (76.2% below).
Latest dividend yield is 0.31% versus a Healthcare sector median of 2.11% (85.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2022 | EUR 248.14M | EUR 8.19M | EUR 18.64M | 8.7% | 1.57 | EUR 23.81M | EUR 2.68M | EUR 147.17M |
| FY2021 | EUR 285.04M | EUR 6.53M | EUR 13.73M | 10.8% | 1.28 | EUR 25.60M | EUR 627.75K | EUR 144.73M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-15 | EUR 69.71M | 5.8 | 0.3% | 0.04 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.04 EUR, yield 0.3%.
| Year | Dividends/share |
|---|---|
| FY2022 | 1.1 EUR |
| FY2021 | 1 EUR |
About Haemato AG
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Haemato AG's market cap?
Haemato AG's market capitalization is EUR 69.71M.
What is Haemato AG's P/E ratio?
Haemato AG's price-to-earnings (P/E) ratio is 5.8.
Does Haemato AG pay a dividend?
Haemato AG has a dividend yield of 0.3%.
What does Haemato AG do?
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases.